|
August 2, 2023
This is to inform you that Concord Biotech Limited is coming out with a public issue to raise Rs.1,550.52 crore from the market.
The issue opens on August 4 and closes on August 8, 2023.
Concord Biotech Limited IPO
| Company Details |
: |
- Concord Biotech Limited is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022 (Source: F&S Report), supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India. They commanded a market share of over 20% by volume in 2022 across identified fermentation-based API products, including mupirocin, sirolimus, tacrolimus, mycophenolate sodium and cyclosporine. (Source: F&S Report) As of March 31, 2023, they had a total installed fermentation capacity of 1,250 m3. In 2016, they launched their formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded to the United States.
- They manufacture (i) bio-pharmaceutical APIs through fermentation and semi-synthetic processes, across the therapeutic areas of immunosuppressants, oncology and anti-infectives; and (ii) formulations, which are used in the therapeutic areas of immunosuppressants, nephrology drugs and anti-infective drugs for critical care.
- They are amongst the few companies globally that have successfully and sustainably established and scaled up fermentation-based API manufacturing capabilities (Source: F&S Report). As of March 31, 2023, they had six fermentation-based immunosuppressant APIs, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus and pimecrolimus.
- They had filed 128 Drug Master Files (“DMFs”) across several countries for their APIs, including 20, 65 and four, respectively, in the United States, Europe and Japan, as of June 30, 2023. DMFs are documents filed by pharmaceutical manufacturers in respect of certain drug products, such as APIs, which contain proprietary information relating to such drug products.
- In India, they market a portfolio of 27 brands across immunosuppressants, nephrology drugs and anti-infective drugs for critical care. They have a presence across 20 states and five union territories in India, through their sales team. They also have a B2B contract development manufacturing organization (“CDMO”) business where they supply immunosuppressants to the Indian market. Their immunosuppressant formulations are manufactured in facilities inspected or accredited by overseas regulators, such as the USFDA, and distributed to the United States and countries in Asia, Africa and Latin America on a B2B basis, primarily through arrangements with distributors.
|
| Issue Period |
: |
Issue opens on: Friday, August 4, 2023
Issue closes on: Tuesday, August 8, 2023
|
| Price Band |
: |
Rs.705 to Rs.741 per equity share |
| Bid Lot |
: |
20 equity shares and in multiple thereafter. |
| Issue Size |
: |
Rs.1,550.52 crore |
| Employee Reservation |
: |
10,000 Equity shares amounting to Rs. 0.67/- crs |
| Employee Discount |
: |
Rs. 70 Per Share |
| Issue break-up |
: |
QIB - 50% of the net offer – Rs.774.92 crore
NIB - 15% of the net offer - Rs.232.48 crore
RET - 35% of the net offer - Rs.542.45 crore |
| Listing |
: |
NSE and BSE |
| Registrar |
: |
Link Intime India Private Limited |
| UPI |
: |
All Retail & NII Bidders (bids up to ₹ 5,00,000) Applications through brokers are compulsorily in UPI Mode |
| Note |
: |
- Application made using third party UPI or ASBA Bank A/c are liable to be rejected.
- “The UPI Mandate acceptance time for Retail and NII Bidders (bids up to ₹ 5,00,000) shall expire at 5:00 PM on the closing day of the IPO i.e., Tuesday, August 08th, 2023 .”
|
Watch these 4 videos to know how to apply for the Concord Biotech Limited IPO online easily.
Step 1: Create an UPI ID
|
Step 2: Apply for IPO online using mobile app or website
|
Step 3: Authorise UPI mandate to block payment
|
Remember these points while applying for IPOs
- With Sharekhan, you can now fill and submit your IPO application online at your convenience anytime before an issue closes. This can be done through the Sharekhan app or website.
- You will need a mobile phone with a SIM linked to your bank account offering the UPI facility and a debit card to create your UPI ID.
- Currently, UPI works on the following mobile applications:
| Name of App (Supported Platforms) |
VPA Handle |
| BHIM Baroda Pay (only Android) |
@BARODAMPAY |
| BHIM Oriental Pay (Only Android) |
@obc |
| BHIM RBL Pay (Android & iOS) |
@rbl |
| BHIM (android & iOS) |
@upi |
| BHIM ALLBANK UPI (only Android) |
@allbank |
| BHIM Axis Pay (only android) |
@axisbank |
| BHIM IndusPay (only Android) |
@indus |
| BHIM Lotza UPI (only Android) |
@federal |
| BHIM SBIPay (only android) |
@sbi |
| Citi Mobile (android & iOS) |
@citi & @citigold |
| Google Pay (android & iOS) |
@okhdfcbank | @okaxis | @oksbi | @okicici |
| HSBC Simply Pay (android & iOS) |
@hsbc |
| iMobile by ICICI Bank (android users) |
@icici |
| Kotak Mobile Banking App (Android) |
@kotak |
| Phone-Pe (android & iOS) |
@ybl |
| SIB Mirror+ (only Android) |
@sib |
| BHIM YES PAY (only Android) |
@yesbank |
| DigiBank - DBS (Android & iOS |
@dbs |
| Paytm (Andriod & iOS) |
@paytm |
| BHIM AUPay (Android & iOS) |
@aubank |
| Freecharge (Android & iOS) |
@freecharge |
| BHIM BANDHAN UPI (Android & iOS) |
@bandhan |
| BHIM KBL UPI (Android) |
@kbl |
| Phone-Pe (Android & iOS) |
@ybl, @axl, @ibl |
- To avoid rejection, download the latest version of the app.
- Remember to select UPI as the payment option in the IPO application form by providing your UPI ID.
- As soon as you submit your application through the mobile app or website, you will receive an SMS from National Payments Corporation of India (NPCI) informing you that your UPI mandate has been generated.
- The app passcode and the UPI PIN can be different; remember to enter only the UPI PIN while authorising the UPI mandate. Note that you should not share your UPI PIN with anyone.
- If you forget the UPI PIN, simply reset it instead of entering a wrong one.
- If the transaction gets through, you will receive a “Transaction is successful” message on your mobile.
- There are two possible scenarios post-allotment: On full allotment, funds will be debited from your account. If there is no allotment of shares, the blocked funds will be released after the end date or expiry date of the UPI mandate.
|
